UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2024 ANEBULO PHARMACEUTICALS, INC (Exact name of Registrant as Specified in Its Charter) Delaware 001-40388 85-1170950 (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No.) Anebulo Pharmaceuticals, Inc. 1017 Ranch Road 620 South, Suite ...